AnaptysBio (ANAB) Stock Chart & Stock Price History $20.44 -0.30 (-1.45%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$20.40 -0.04 (-0.20%) As of 05/23/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AnaptysBio Stock Price Performance The AnaptysBio (ANAB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 14.51%, with a year-to-date return of 54.38%. In the past month, the stock has decreased 1.26%, reflecting recent market activity. As of the latest close, AnaptysBio traded at $20.44 with a market cap of $600.53 million and volume of 357,651 shares. Five years ago, the stock traded at $19.87, representing a 2.87% increase over that period. At the time, it had a market cap of $541.99 million and a volume of 259,574 shares. Receive ANAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.13%1 Month Performance-1.26%3 Month Performance+18.91%Year-To-Date Performance+54.38%1 Year Performance-14.51%5 Year Performance+2.87% ANAB Stock Chart for Sunday, May, 25, 2025 ANAB Chart by TradingView AnaptysBio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/23/2025$20.74$20.44-1.45%$20.75$20.03357,651 shs$600.53 million05/22/2025$20.81$20.74-0.34%$21.33$20.41360,420 shs$609.34 million05/21/2025$21.10$20.81-1.37%$21.31$20.36492,110 shs$611.40 million05/20/2025$20.47$21.10+3.08%$21.63$20.03470,433 shs$619.92 million05/19/2025$20.22$20.47+1.24%$20.73$19.93434,133 shs$601.41 million05/16/2025$20.40$20.22-0.88%$20.73$19.98355,554 shs$594.06 million05/15/2025$19.45$20.40+4.88%$20.79$19.21363,930 shs$599.35 million05/14/2025$20.52$19.45-5.21%$20.76$19.20404,073 shs$571.44 million05/13/2025$20.03$20.52+2.45%$20.97$19.38541,714 shs$602.88 million05/12/2025$19.59$20.03+2.25%$21.14$19.79470,952 shs$588.48 million Get the Latest News and Ratings for ANAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. 05/09/2025$19.58$19.59+0.05%$20.04$19.09421,018 shs$579.36 million05/08/2025$19.61$19.58-0.15%$20.02$18.51554,439 shs$579.06 million05/07/2025$20.12$19.61-2.54%$20.64$19.25710,737 shs$579.92 million05/06/2025$20.73$20.12-2.94%$21.52$19.94731,686 shs$595.03 million05/05/2025$21.19$20.73-2.17%$21.00$20.17370,308 shs$613.07 million05/02/2025$21.70$21.19-2.35%$21.90$21.15294,391 shs$649.83 million05/01/2025$22.22$21.70-2.34%$22.24$21.22345,994 shs$665.47 million04/30/2025$21.18$22.22+4.91%$22.52$21.05581,339 shs$681.42 million04/29/2025$21.33$21.18-0.70%$21.66$20.98346,034 shs$649.53 million04/28/2025$20.70$21.33+3.04%$21.42$20.80319,755 shs$654.13 million04/25/2025$20.61$20.70+0.44%$21.14$20.17306,123 shs$634.81 million04/24/2025$20.42$20.61+0.93%$20.68$19.57690,738 shs$632.05 million Related Companies Xenon Pharmaceuticals Stock Chart Amneal Pharmaceuticals Stock Chart HUTCHMED Stock Chart Organon & Co. Stock Chart Mirum Pharmaceuticals Stock Chart Apellis Pharmaceuticals Stock Chart Arrowhead Pharmaceuticals Stock Chart Vericel Stock Chart NewAmsterdam Pharma Stock Chart Gemini Therapeutics Stock Chart Receive ANAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AnaptysBio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ANAB) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AnaptysBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AnaptysBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANAB Stock Free ANAB Stock Alerts